US is reviving shuttered nuclear plants to meet growing electricity demand and to power data centers
The United States is making an unprecedented attempt to revive three shuttered nuclear plants to meet growing demand, ...
When studying programming, you notice something strange.Processes that are extremely complex for humans to think through can ...
Division II joins Division III in using NPI for championship selections, beginning in 2026-27. At its core, NPI is designed ...
You have an AI write code. You have it check for errors and propose fixes. A human looks at the results and chooses what ...
OpenAI released a set of proposals for safety and security in the development of frontier AI in a blog post. The ChatGPT maker focused on alignment research and recursive self-improvement, or RSI.
“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...
HOUSTON – At the G20 Energy Abundance Ministerial today in Houston, Texas, U.S. Environmental Protection Agency (EPA) Administrator Lee Zeldin announced the repeal of the majority of the Biden ...
The Lord of the Rings is coming back to physical media in a big way this fall, giving fans another chance to bring a piece of Middle-earth home just as the franchise prepares for its next major ...
SEOUL, Sept 8 (Reuters) - (This Sept 8 story has been refiled to fix typos in captions.) Sign up here. Those AI-driven power needs alone will lift South Korea's demand for power by 25 to 30 gigawatts, ...
Konami Digital Entertainment has officially announced Glorious Victors, the next booster set for the Yu-Gi-Oh! Trading Card Game, scheduled to hit retail shelves on December 4, 2026. The 60-card set ...
AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...
Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results